Showing: 1 - 10 of 19 RESULTS

Belly bulge: Causes and treatments

Weight gain is a simple explanation for a belly bulge, but there may be other causes. Some people carry a belly bulge for life while others notice growth over time.

In this article, we examine the different causes of belly bulge and their treatment or prevention. We also assess when to see a doctor.

Whether a person has a moderate weight or obesity, their body fat can distribute in several ways.

Subcutaneous fat makes up the majority of belly fat. This sits just below the skin, and is pinchable.

However, visceral fat is another type of belly fat that lies inside the abdominal cavity between the organs. Research suggests it has links with several diseases, including hypertension, heart disease, and type 2 diabetes.

While visceral body fat mechanisms are unknown, one study reports that genetics play a significant factor.

Weight gain is a serious problem in the United States. The Centers for Disease Control and Prevention (CDC) report that 42.4% of U.S. adults had overweight in 2017–2018.

A small amount of belly fat is relatively harmless. However, the larger the bulge, the higher the chance of serious illness.

Several factors can cause a belly bulge.

Getting older

A person’s body composition changes as they age, which can lead to a belly bulge.

For females, the decrease in the hormone estrogen during menopause triggers an accumulation of body fat. Fat tissues produce estrogen, so more is produced after menopause to create a balance.

Levels of the hormone progesterone also decrease, which can lead to water weight gain and bloating.

The accumulation of belly fat is a natural result of these hormonal and metabolic changes.

For males and females, muscle tissue, muscle mass, and the capacity to burn calories decrease with age.

Therefore, if a person keeps consuming the same number of calories every day, fat naturally increases.

Stress

In the modern world, day-to-day stress majorly impacts on people’s health and well-being. It not only affects the body psychologically — it also interferes with its ability to function normally.

The American Institute of Stress report that 77% of people regularly experience physical symptoms of stress.

Possible physical side effects include unwanted belly fat. This relates to the stress hormone cortisol, which is created in the body’s adrenal glands. Cortisol affects fat storage around the lower abdomen, while its receptors are found deep within visceral fat.

This hormone provides a physical boost during exercise. However, it also induces acute stress. While working in the brain, it helps control mood and motivation.

Cortisol also manages how the body uses carbohydrates, fats, and proteins. It regulates blood pressure and can increase blood sugar levels. If a person is stressed, cortisol increases their need to consume sweet or comforting foods and drinks.

Research shows that chronically stressed individuals are more vulnerable to a high-fat, high-sugar diet.

Bloating

Also called distension, bloating occurs for many reasons. These include:

The feeling of pressure or swelling in the stomach from bloating should not usually be a cause for concern.

Warrnambool Dental, a Top-Rated Dentist Warrnambool, VIC Announces Cosmetic and Dental Implant Treatments

(MENAFN – GetNews)

Warrnambool, VIC – Warrnambool Dental is proud to announce the inclusion of cosmetic and dental implant treatments as part of the dental services that they offer. The new treatment is a welcoming alternative to dentures which can be uncomfortable if worn for long extended periods of time.

‘For the permanent replacement of missing teeth, Warrnambool Dental offers patients an incredibly effective and natural-looking solution. By choosing dental implants in replacing missing teeth, you can restore your dental health by correcting your bite and protecting the integrity of your jawbone and adjacent teeth, said Dr. Nishant Hurria, the spokesperson for the dental practice, regarding their unrivaled services.

There are several causes of tooth loss. It could be decaying teeth, fractured teeth, periodontal disease, or trauma-related accidents. Patients can now get cosmetic and dental implants with the same level of care and quality when they get in touch with Warrnambool Dental.

The dental practice is all about restoring patients’ smiles that will last for years to come. In addition to cosmetic and dental implant treatments, patients can also get general dental and full mouth rehabilitation treatments. The team at Warrnambool Dental is focused on balancing the dental needs and personal goals of their patients.

Smile Makeovers

Dr. Nishant Hurria has a combination of experience, advanced technique, and a good eye for aesthetics to ensure that patients are smiling when they leave his office. The whole practice takes great pride in providing comprehensive dental procedures so that patients are leaving better than when they visited the clinic for the first time.

Full Mouth Rehabilitation

A bad bite, tooth decay, periodontal disease, and more can result in the teeth needing to be repaired or replaced. Dr. Nishant Hurria offers full mouth rehabilitation treatment that helps in restoring smiles with pain-free confidence. The dentist has the training and experience to evaluate and correct issues with bite. Patients can rest easy knowing that they’re working with a  dentist Warrnambool that cares about providing quality dental care and treatment services.

Dental Implants

Patients that have lost their teeth through an accident or periodontal disease can now get in touch with Warrnambool Dental. The teeth that are replaced look and are just as functional as natural teeth. Dr. Nishant Hurria will ensure that the procedure is done safely and efficiently utilizing the best practices.

New Patients are Always Welcome

For patients looking for a reliable family dentist or someone to perform cosmetic procedures, there is an expert team at Warrnambool Dental that is always ready to provide high-quality dental care and treatment services.

Getting the right dentist is imperative for good oral health. Warrnambool Dental has also made it easy to book dental appointments so that patients don’t have to wait for weeks before seeing the right provider. Most insurance plans are accepted so that patients have access to high-quality dental treatment. The team at Warrnambool Dental will ensure that patients are always comfortable and feeling at home whenever they visit their offices.

To get

Dentist North Lakes, Passion Family Dental North Lakes Announces General Dental Treatments in QLD – Press Release

Dentist North Lakes, Passion Family Dental North Lakes Announces General Dental Treatments in QLD

North Lakes, QLD – Getting a dentist that can be trusted with the oral health of the family is always going to be a challenging undertaking. Such a provider could have all the experience in the world but still fails to get along with the patients. Passion Family Dental North Lakes is all about providing compassionate dental care and treatment services for the residents of North Lakes, QLD. The practice was founded on the premise of providing high-quality dental care & treatment services in a safe and comfortable environment. That is why the clinic has decided to announce the reaffirmation of its commitment by providing general dental treatments.

“At Passion Family Dental North Lakes, we are committed to understanding and working together with you to help take control of your oral health. We recognize that some people find going to the North Lakes dentist a daunting experience, our staff has many years of experience and has gained skills in helping nervous patients overcome their fears. You can relax knowing that you are in very caring hands,” said Dr. Sam Ooi, the spokesperson for the dental clinic, regarding their unrivaled staff.

Passion Family Dental North Lake’s sole focus is on providing quality dental care at affordable prices. There is no reason why a patient should have to go through the pain and agony when they can reach out to the clinic for all of their dental treatment needs.

There is no patient that likes to be surprised with a hefty bill at the end of an appointment. That is why the clinic always makes an effort to make the patients aware of the cost of treatment before it can commence. Patients can go through the different prices on their website, depending on the type of treatment that they’re looking for.

For assistance with payment, Passion Family Dental North Lakes offers no-interest plans that patients can take advantage of so that they’re not missing out on high-quality dental treatments.

Searching for a dentist North Lakes has never been easier than with Passion Family Dental North Lakes. All patients have to do is go online and book an appointment. No more waiting for weeks before seeing a dentist. The practice understands that patients have unique needs when it comes to dental care and treatment. They start by listening to the patient while taking into consideration their needs and requirements. Since they have the patients’ best interest at heart, patients can be assured of getting a warm and pleasant dental experience.

However, going to the dentist is not always a pleasant experience. This a fact that Passion Family Dental North Lakes understands all too well. Their staff will go above and beyond to ensure that patients are always comfortable when they visit their clinic. Dr. Sam Ooi will never rush an appointment and will make sure that each patient feels at home when they visit. Patients can expect to be treated with the utmost respect and in a gentle manner.

Visit Passion Family Dental

Warrnambool Dental, a Top-Rated Dentist Warrnambool, VIC Announces Cosmetic and Dental Implant Treatments – Press Release

Warrnambool Dental, a Top-Rated Dentist Warrnambool, VIC Announces Cosmetic and Dental Implant Treatments

Warrnambool, VIC – Warrnambool Dental is proud to announce the inclusion of cosmetic and dental implant treatments as part of the dental services that they offer. The new treatment is a welcoming alternative to dentures which can be uncomfortable if worn for long extended periods of time.

“For the permanent replacement of missing teeth, Warrnambool Dental offers patients an incredibly effective and natural-looking solution. By choosing dental implants in replacing missing teeth, you can restore your dental health by correcting your bite and protecting the integrity of your jawbone and adjacent teeth,” said Dr. Nishant Hurria, the spokesperson for the dental practice, regarding their unrivaled services.

There are several causes of tooth loss. It could be decaying teeth, fractured teeth, periodontal disease, or trauma-related accidents. Patients can now get cosmetic and dental implants with the same level of care and quality when they get in touch with Warrnambool Dental.

The dental practice is all about restoring patients’ smiles that will last for years to come. In addition to cosmetic and dental implant treatments, patients can also get general dental and full mouth rehabilitation treatments. The team at Warrnambool Dental is focused on balancing the dental needs and personal goals of their patients.

Smile Makeovers

Dr. Nishant Hurria has a combination of experience, advanced technique, and a good eye for aesthetics to ensure that patients are smiling when they leave his office. The whole practice takes great pride in providing comprehensive dental procedures so that patients are leaving better than when they visited the clinic for the first time.

Full Mouth Rehabilitation

A bad bite, tooth decay, periodontal disease, and more can result in the teeth needing to be repaired or replaced. Dr. Nishant Hurria offers full mouth rehabilitation treatment that helps in restoring smiles with pain-free confidence. The dentist has the training and experience to evaluate and correct issues with bite. Patients can rest easy knowing that they’re working with a dentist Warrnambool that cares about providing quality dental care and treatment services.

Dental Implants

Patients that have lost their teeth through an accident or periodontal disease can now get in touch with Warrnambool Dental. The teeth that are replaced look and are just as functional as natural teeth. Dr. Nishant Hurria will ensure that the procedure is done safely and efficiently utilizing the best practices.

New Patients are Always Welcome

For patients looking for a reliable family dentist or someone to perform cosmetic procedures, there is an expert team at Warrnambool Dental that is always ready to provide high-quality dental care and treatment services.

Getting the right dentist is imperative for good oral health. Warrnambool Dental has also made it easy to book dental appointments so that patients don’t have to wait for weeks before seeing the right provider. Most insurance plans are accepted so that patients have access to high-quality dental treatment. The team at Warrnambool Dental will ensure that patients are always comfortable and feeling at home whenever they visit their offices.

To get a reliable dentist

Can Trump Really Speed Approval of Covid Treatments?

The Bioshield Act, along with the laws that later modified it, was not intended as a carte blanche. For instance, an E.U.A. can only be granted during a declared public health or national security emergency, and is supposed to be used only for products that have no adequate, approved or available alternatives. But the F.D.A. was granted wide discretion to decide whether a product ought to be made available to the public. By law, the agency can grant E.U.A.s to products that “may be effective,” whose “known and potential benefits” outweigh “the known and potential risks.” It is up to the agency, however, to determine what those criteria mean.

“It was deliberately a quite flexible kind of standard,” said Dr. Jesse Goodman, the director of the Center on Medical Product Access, Safety and Stewardship at Georgetown, and the F.D.A.’s chief scientist from 2009 to 2014. E.U.A.s are intended to be evaluated on a case-by-case basis; the F.D.A. might tolerate more risk for a drug designed to treat a disease with a high mortality rate, such as Ebola, than for a vaccine that would be given to healthy people to stop a disease like Covid-19, Mr. Goodman said.

But, he added, E.U.A.s were not meant as a substitute for traditional approvals: “The intent originally was that ultimately you should be collecting data and moving these products toward approval,” even after the emergency authorization was granted.

However, it can be difficult to fully enroll a product in clinical trials after it has received an E.U.A., Dr. Goodman said, because clinical trials typically impose more stringent requirements on patients than an E.U.A. would. “Now we have tens of thousands of people getting convalescent plasma” — a Covid-19 treatment that was granted an E.U.A. in August — “and we still don’t know whether it works,” he said.

Another potential hazard of emergency authorization became apparent not long after the Bioshield Act was signed into law, when the F.D.A. granted its first E.U.A., at the request of the Defense Department, for the use of an anthrax vaccine, in 2005. That authorization suggested to some people, including Chris Shays, then a Republican congressman from Connecticut, that the E.U.A. process provided an avenue for political interference. The apparent urgency “appears to be the product of preventable legal and regulatory failures,” Mr. Shays wrote in a letter to the Secretary of Health and Human Services, “rather than any validated external threat.”

The actions of the Trump administration during the Covid pandemic have renewed these concerns. In May, Rick Bright, the former head of the Biomedical Advanced Research and Development Authority, alleged in a whistle-blower complaint that he had arranged an E.U.A. request for hydroxychloroquine and chloroquine as a “compromise position” to head off pressure by administration officials to make the drugs available under a less-restrictive protocol known as “expanded access.”

In late September, Mr. Trump said that he was considering blocking the F.D.A.’s vaccine E.U.A. guidelines, which made it unlikely that a vaccine would be authorized before the

Trump’s doctor says he’s completed his Covid-19 treatments and can return to ‘public engagements’ on Saturday.

President Trump’s doctor said on Thursday that he’s completed his treatments to alleviate the symptoms of the coronavirus and that he anticipates that the president will be able to resume “public engagements” on Saturday.

The forecast about Mr. Trump’s condition came from the White House physician, Dr. Sean Conley, in a note updating people on his health. Mr. Trump announced shortly before 1 a.m. on Friday, Oct. 2, that he and the first lady, Melania Trump, had tested positive for the virus; White House officials have declined to say when he last tested negative.

He was taken to Walter Reed National Military Medical Center Friday afternoon. Officials initially described the president’s symptoms as mild, but The Times and other news organizations reported Saturday that Mr. Trump had been administered supplemental oxygen because his blood oxygen dropped to a level that was concerning. His lung scans had “expected findings,” Dr. Conley said on Sunday, although he declined to say what that meant.

In the note on Thursday, Dr. Conley said that Mr. Trump has remained “stable” and “devoid” of symptoms that would suggest the illness was progressing.

“Saturday will be day 10 since Thursday’s diagnosis, and based on the trajectory of advanced diagnostics the team has been conducting, I fully anticipate the president’s safe return to public engagements at that time,” Dr. Conley said.

The Centers for Disease Control and Prevention says those who test positive for the coronavirus should isolate themselves from others for a minimum of 10 days after testing positive, or for at least 10 days after symptoms first appear. Some people with a moderate or severe case of the virus can stay infectious for 20 days or perhaps even longer, according to the C.D.C.

Shortly after Dr. Conley’s memo, Mr. Trump’s re-election campaign released a statement calling for the second presidential debate to take place as originally scheduled. “There is therefore no medical reason why the Commission on Presidential Debates should shift the debate to a virtual setting, postpone it, or otherwise alter it in any way,” the statement said.

Source Article

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

When the Trump administration suspended federal funding in 2019 for most new scientific research projects involving fetal tissue derived from abortions, officials argued that whatever the scientific benefits, there was a pressing moral imperative to find alternative research methods.

“Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” the Department of Health and Human Services said in a statement released at the time.

Yet the treatment for Covid-19 received by Mr. Trump — a cocktail of monoclonal antibodies he described as a “cure” in a celebratory video posted on Twitter — was developed using human cells derived from a fetus aborted decades ago.

Remdesivir, an antiviral drug that the president received late last week, was also developed with those cell lines. At least two companies racing to create a vaccine against the coronavirus, Moderna and AstraZeneca, are also relying on the cells. Johnson & Johnson is testing its vaccine in another so-called cell line originally produced from fetal tissue.

As participants in the White House’s Operation Warp Speed, all three vaccine-makers have received federal funding.

A Trump administration official argued on Thursday that the president’s embracing of the treatments was not a contradiction. The administration’s policy on fetal tissue research “specifically excluded” cell lines made before June 2019, said the official, who did not wish to be identified because he was not authorized to speak about the matter.

Scientific products made using cell lines that existed before then “would not implicate the administration’s policy on the use of human fetal tissue from elective abortions,” the official said.

Some scientists saw a double standard in the president’s endorsement. “Hypocrisy has never bothered the man, as near as I can tell,” Lawrence Goldstein, a neuroscientist at the University of California, San Diego, who has used fetal tissue in his research, said of Mr. Trump.

Dr. Deepak Srivastava, a pediatric cardiologist who led the International Society for Stem Cell Research until July, said, “If they oppose this research, they should be willing to not take a drug that was developed using that.”

For decades, fetal tissue from abortions has been crucial to scientific research into treatments for conditions from birth defects to Ebola to cancer. And fetal tissue has been particularly important for studying the immune system, a key to designing treatments and vaccines for infectious diseases like Covid-19.

The cells used by most of the companies now trying to find a Covid-19 treatment, called the 293T line, were derived from the kidney tissue of a fetus aborted in the 1970s. A similar cell line, Per.C6, was obtained in 1985 from the retinal cells of an aborted 18-week-old fetus.

The treatment that Mr. Trump called a cure for Covid-19 is a cocktail of two monoclonal antibodies manufactured by Regeneron. Those antibodies are synthesized outside the body and then infused into patients to help fight off the infection.

Regeneron tested the antibodies against virus-like particles created using 293T human cells. The

Trump politicizes promising coronavirus antibody treatments, erroneously calling them a ‘cure’

Trump also claimed in the videos he had granted the drugs an emergency use authorization (EUA), a designation that would make the medicines more broadly available. But the companies said they have submitted the requests to the Food and Drug Administration — a process that the agency has repeatedly tried to assure the public is based on science and free of political interference.

“We’re going to make them available immediately, we have an emergency use authorization that I want to get signed immediately,” Trump said in the video posted Thursday afternoon.

Experts said that by inserting himself and his own recovery story into an area of ongoing medical research, Trump risks disappointing and confusing the American public with a hopeful anecdote that may not reflect how the drug works for others or how broadly it will become available when it is approved, which he also promised would be free.

“The fundamental problem with monoclonal antibodies is there’s not enough worldwide capacity to produce enough of them to have a real impact on the disease,” said Ezekiel Emanuel, a health policy expert who is advising the campaign of Joe Biden. “Yes, they might be great, but for a small number of patients.”

The president also said in the video that people in hospitals should receive the drugs, but the data so far supports using them in people with mild or moderate illness who are recently diagnosed. Early data from ongoing studies have shown evidence the drugs reduce symptoms over days, knock back the virus by reducing levels in the body and may cut down the need for further medical visits. That data is considered very promising, but not definite evidence of a cure.

Trump’s endorsement of monoclonal antibodies comes as the authorization of a coronavirus vaccine before Election Day appears increasingly unlikely. Such an okay had loomed as a potential “October surprise” that some believed could alter the course of the election with the prospect of a quick return to normalcy. An influential medical journal argued in an editorial Wednesday that the Trump administration’s handling of the pandemic took “a crisis and turned it into a tragedy,” so the antibody drugs could offer a rare victory.

Trump said in one video that the therapies were “more important” than the vaccine, the same day that both companies disclosed that they had filed with regulators for emergency authorization to use the drugs in some patients. On Fox Business on Thursday morning, he called the Regeneron drug “a gift from heaven.”

Both the Regeneron and Eli Lilly drugs are being tested in clinical trials, and no one knows if the former helped Trump recover, whether it did so in addition to all the other treatments he received or whether he would have recovered on his own as part of the natural course of the disease.

Several experts said that Trump touting a drug as a cure will make it even harder to persuade patients to participate in ongoing clinical trials where they will have

Knopp Biosciences NIH-Funded Pain Program Advances to Second Year of HEAL Award to Discover Non-Opioid Treatments for Chronic Pain

Knopp Biosciences LLC today announced that it entered the second year of research funded by the National Institutes of Health (NIH) to utilize its Kv7 platform to discover and develop non-opioid therapies for the treatment of chronic pain. The project is funded by the NIH program called Helping to End Addiction Long-term (the NIH HEAL Initiative), which aims to improve treatments for chronic pain, curb the rates of opioid use disorder and overdose, and achieve long-term recovery from opioid addiction.

Knopp has developed a discovery platform of proprietary molecules directed to a non-opioid biological target linked to chronic pain caused by damage to nerves. The drug target is a cellular membrane potassium channel called Kv7.2/7.3, which regulates the flow of electrically charged ions required to modulate the excitability of cells. Growing scientific evidence suggests that selectively activating key Kv7 channel subtypes can control nerve-cell hyperexcitability associated with chronic pain.

“Knopp is pleased that the achievement of year one milestones positioned the company to continue research on solutions for this public health crisis,” said Michael Bozik, M.D., Chief Executive Officer of Knopp. “In year two, we expect to identify a molecule from our Kv7 platform that is suitable for further development as a potential non-opioid treatment for patients suffering from certain types of chronic pain.”

The grant funding of as much as $8 million is contingent upon the attainment of milestones over five years. Knopp’s HEAL award was one of 375 grants made across 41 states in fiscal year 2019 to apply scientific solutions to help reverse the national opioid crisis.

Knopp’s Kv7 research is supported in part under Award Number U44NS093160 and Award Number U44NS115732 of the National Institute of Neurological Disorders and Stroke of the NIH. The content of this announcement is solely the responsibility of Knopp and does not necessarily represent the views of the NIH.

ABOUT KNOPP BIOSCIENCES LLC

Knopp Biosciences is a privately held drug discovery and development company focused on delivering breakthrough treatments for immunological and neurological diseases of high unmet need. Knopp’s clinical-stage oral small molecule, dexpramipexole, is in Phase 2 clinical trials in moderate-to-severe eosinophilic asthma. Knopp’s preclinical Kv7 platform is directed to small molecule treatments for developmental and epileptic encephalopathies, other rare epilepsies, neuropathic pain, and tinnitus. Please visit www.knoppbio.com.

ABOUT THE NIH HEAL INITIATIVE

The Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, is an aggressive, trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis. Launched in April 2018, the initiative is focused on improving prevention and treatment strategies for opioid misuse and addiction, and enhancing pain management. For more information, visit: https://heal.nih.gov.

This press release contains “forward-looking statements,” including statements relating to planned regulatory filings and clinical development programs. All forward-looking statements are based on management’s current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including the uncertainties inherent in clinical trials and product development programs, the availability of funding to support continued research

Myocarditis: Causes, Symptoms and Treatments

It seems like we have been in the midst of the COVID-19 pandemic forever, but in reality the disease has been around for less than one year. That’s not a long time, as far as new diseases go, and scientists are learning more and more about it all the time. Indeed, given this relatively short timespan, it’s hard to know what the long-term effects of the coronavirus may be. However, clinicians and researchers are noticing a connection between COVID-19 and heart disease.

(Getty Images)

In particular, patients infected by the novel coronavirus often develop a worrisome inflammation of the heart muscle. Known as myocarditis, this inflammation potentially can produce serious heart disease. In a July 2020 study published in JAMA Cardiology, researchers discovered that 78 out of 100 patients recovering from COVID-19 had some kind of cardiac impairment, and 60 of those had myocarditis after recovering, independent of whether or not they had preexisting conditions or how severe their COVID-19 symptoms were.

“We were not expecting that,” says Dr. Sandra Chaparro, a cardiologist at the Miami Cardiac and Vascular Institute who specializes in heart failure and transplantation cardiology and serves as the director of advanced heart failure. That study’s small sample size makes it hard to know just how widespread the incidence of myocarditis really is, she says. But anecdotal evidence from around the world – including at her institute, which has treated several patients with the condition – suggests it’s worth monitoring.

“We’ve seen it in young and old patients,” Chaparro says. One patient in his 40s recovered from COVID-19 but had signs of heart damage after. However, the connection is still far from clear. “Sometimes it’s hard to figure out if it was caused by something else or a preexisting condition. And we don’t know what the rate (of myocarditis) is of asymptomatic patients,” she adds. But the data and case studies are raising alarms.

What Is Myocarditis?

Myocarditis is any inflammation of the heart muscle, says Dr. Karol Watson, a cardiologist and a professor of medicine/cardiology at the David Geffen School of Medicine at UCLA. This inflammation can have many causes. A virus like the coronavirus is one of the most common causes, but bacterial infections, chemotherapy drugs or a dysfunctional immune system may also be behind it.

Myocarditis can disrupt the heart’s ability to pump blood and impair the electrical signaling that keeps it beating regularly. It can be mild, and most people do not have a lot of symptoms, if any, Chaparro says. In severe cases, myocarditis can cause abnormal heart rhythms, heart muscle disease and heart failure. These patients may need medication and/or mechanical support, like heart pumps, and a small number of patients require heart transplant, she says.

How Does COVID-19 Affect the Heart?

The coronavirus may cause inflammation in up to three ways. “Like any virus, it can directly attack the heart muscle, causing inflammation and myocarditis,” says Watson, who is also director of the UCLA Women’s Cardiovascular Health Center and the